Pfizer to allow generic drug companies to make its COVID-19 pill

Pfizer to allow generic drug companies to make its COVID-19 pill


Pfizer announced a licensing agreement Tuesday to allow other manufacturers to produce its experimental COVID-19 pill to treat people in 95 developing countries – where more than half of the world’s population lives.

The drugmaker said in a statement it signed a deal with a UN-backed group, the Geneva-based Medicines Patent Pool, to let generic drug companies produce its antiviral pill, Paxlovid, which has yet to be authorized, in low- and middle-income nations.

“This license is so important because, if authorized or approved, this oral drug is particularly well-suited for low- and middle-income countries and could play a critical role in saving lives, contributing to global efforts to fight the current pandemic,” MPP executive director Charles Gore said.

Trending: MORE Names Revealed In Epstein’s ‘Black Book’

As part of the deal,

Continue reading

You Might Like

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!
Send this to a friend